E. Vizcaino

E. Vizcaino

Auto-generated profile, based on publicly available information

E. Vizcaino

Institut Català de la Salut

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2026 in Journal of Pharmaceutical Policy and Practice
Verified
Journal Article
Open access
CRC. Rovira
C. Rovira
MCM. Casanovas
M. Casanovas
EVE. Vizcaino
E. Vizcaino
MMM. Massanés
M. Massanés
QCQueralt Miró Catalina
Queralt Miró Catalina
PMPilar Modamio
Pilar Modamio
The person-centred care model involves a multidisciplinary team providing individualised health and social care aligned with patient preferences and health goals. Although some evidence supports its use in primary care, it remains under-evaluated. This study aimed to evaluate the effectiveness of a Collaborative Medication Management (CMM) approach in optimising pharmacotherapy plans versus usual care among polymedicated older adults. A randomised, open-label, multicentre, parallel clinical trial was conducted across 11 Primary Care Teams in Spain (Sept 2020–Jan 2024), including patients aged ≥75 years taking ≥8 chronic medications with complex or advanced conditions. The intervention group (IG, n = 102) received CMM delivered by a multidisciplinary team, including structured medication review, development of a patient-centred care plan, and follow-up at 6 and 12 months. The control group (CG, n = 106) received usual care. Primary outcomes were number of medications, drug-related prescriptions (DRP), changes to pharmacotherapy plans, and hospital admissions. Secondary outcomes included persistence of changes at 12 months and medication-related safety incidents. A total of 208 subjects were included (65.4% women; mean age 83.6 ± 6.3 years). IG showed a mean reduction of 1.8 ± 2.1 medications/patient vs. an increase of 0.3 ± 1.4 in CG (p = 0.004); a mean reduction of 2.9 ± 2.5 DRP/patient in IG vs. An increase of 0.2 ± 1.2 in CG (p = 0.004); a mean of 4.3 ± 2.9 changes to pharmacotherapy plans in IG vs. 2.6 ± 3.3 in CG (p = 0.004); a mean of 0.3 ± 0.7 hospital admissions in IG vs. 0.3 ± 0.8 in CG (p = 1.000). Persistence of changes at 12 months was 3.8 ± 2.7 in IG vs. 2.2 ± 2.9 in CG (p < 0.001). In addition, a mean of 0.5 ± 0.7 safety incidents was reported in IG vs. 0.5 ± 1.0 in CG (p = 0.676). The person-centred care model proved effect in optimising medication use in polymedicated older adults. Trial registration: ClinicalTrials.gov identifier: NCT04188470.